9997 — Kangji Medical Holdings Share Price
0.000.00%
Last trade - 00:00- HK$7.96bn
- HK$5.41bn
- CNY926.02m
- 86
- 55
- 49
- 74
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 12 | ||
| PEG Ratio (f) | 1.03 | ||
| EPS Growth (f) | 13.2% | ||
| Dividend Yield (f) | 4.05% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.02 | ||
| Price to Tang. Book | 2.3 | ||
| Price to Free Cashflow | 22.17 | ||
| Price to Sales | 7.94 | ||
| EV to EBITDA | 8.02 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 14.51% | ||
| Return on Equity | 14.35% | ||
| Operating Margin | 63.82% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 503.47 | 511.49 | 690.26 | 786.37 | 926.02 | 1,134.23 | 1,344.94 | 21.23% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +40.82 | +43.14 | +28.85 | +6.83 | +8.68 | +11.51 | +16.67 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Kangji Medical Holdings Ltd is a China-based investment holding company mainly engaged in the design, development, manufacture and sale of minimally invasive surgical instruments and accessories. The Company's main products include disposable trocars, polymer ligation clips, disposable electrocoagulation forceps and other disposable products, which are used in gynecology and obstetrics, urology, general surgery and thoracic surgery. The Company distributes its products within the domestic market and to overseas markets.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- August 1st, 2004
- Public Since
- June 29th, 2020
- No. of Employees
- 1,003
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 1,214,821,000
- Address
- No. 1668 Chunjiang East Road, HANGZHOU
- Web
- https://www.kangjimedical.com/
- Phone
- Auditors
- Ernst & Young CPA
Upcoming Events for 9997
Dividend For 9997.HK - 0.4100 CNY
Half Year 2024 Kangji Medical Holdings Ltd Earnings Release
Similar to 9997
Acotec Scientific Holdings
Stock Exchange of Hong Kong Limited
Beijing Airdoc Technology Co
Stock Exchange of Hong Kong Limited
AK Medical Holdings
Stock Exchange of Hong Kong Limited
AMCO United Holding
Stock Exchange of Hong Kong Limited
Angelalign Technology
Stock Exchange of Hong Kong Limited
FAQ
What is the Kangji Medical Holdings share price?
As of Today at 19:12 UTC, shares in Kangji Medical Holdings are trading at HK$6.55. This share price information is delayed by 15 minutes.
How has the Kangji Medical Holdings share price performed this year?
Shares in Kangji Medical Holdings last closed at HK$6.55 and the price had moved by -37.86% over the past 365 days. In terms of relative price strength the Kangji Medical Holdings share price has underperformed the FTSE Developed Asia Pacific Index by -35.14% over the past year.
What are the analyst and broker recommendations for Kangji Medical Holdings?
The overall consensus recommendation for Kangji Medical Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Kangji Medical Holdings dividend yield?
The Kangji Medical Holdings dividend yield is 6.77% based on the trailing twelve month period.
Does Kangji Medical Holdings pay a dividend?
Last year, Kangji Medical Holdings paid a total dividend of CNY0.41, and it currently has a trailing dividend yield of 6.77%.Looking ahead, shares in Kangji Medical Holdings are due to go ex-dividend on 2024-05-29 and the next dividend pay date is 2024-07-18.
When does Kangji Medical Holdings next pay dividends?
Kangji Medical Holdings are due to go ex-dividend on 2024-05-29 and the next dividend pay date is 2024-07-18. The historic dividend yield on Kangji Medical Holdings shares is currently 6.77%.
How do I buy Kangji Medical Holdings shares?
To buy shares in Kangji Medical Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Kangji Medical Holdings?
As of the previous close price of HK$6.55, shares in Kangji Medical Holdings had a market capitalisation of HK$7.96bn.
Where are Kangji Medical Holdings shares listed?
Here are the trading details for Kangji Medical Holdings:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 9997
What kind of share is Kangji Medical Holdings?
Based on an overall assessment of its quality, value and momentum Kangji Medical Holdings is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Kangji Medical Holdings share price forecast for 2024?
The analyst consensus target price for shares in Kangji Medical Holdings is HK$10.04. That is 53.33% above the last closing price of HK$6.55.
Analysts covering Kangji Medical Holdings currently have a consensus Earnings Per Share (EPS) forecast of CNY0.48 for the next financial year.
What is the trend in the Kangji Medical Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Kangji Medical Holdings. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +0.26%.
As of the last closing price of HK$6.55, shares in Kangji Medical Holdings were trading -6.37% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Kangji Medical Holdings PE Ratio?
The Kangji Medical Holdings PE ratio based on its reported earnings over the past 12 months is 12. The shares last closed at HK$6.55.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Kangji Medical Holdings?
We do not have data on Kangji Medical Holdings' directors